Four axes from current statute and agency guidance. Teal bar = substitution/assistance/access in place; amber = permissive or absent.
| Generic substitution mandate | Mandatory by statute |
| State Pharmaceutical Assistance Program | PAAD / Senior Gold |
| 90-day fills permitted | Allowed |
| PMP mandatory prescriber query | Required by statute |
New Jersey mandates generic substitution. Under N.J.S.A. § 24:6E-1 et seq. (Generic Drug Substitution Act), a pharmacist shall dispense a less expensive equivalent drug product unless the prescriber writes "do not substitute" in their own handwriting on the prescription. The substitute must be on the New Jersey Generic Drug Formulary maintained by the State Board of Pharmacy.
New Jersey administers Medicaid pharmacy benefits through NJ FamilyCare via Magellan Medicaid Administration. The state maintains a Preferred Drug List used across managed-care organizations and fee-for-service. Non-preferred drugs require prior authorization initiated by the prescriber.
Preferred Drug List: View current PDL
Prior authorization contact: NJ FamilyCare Pharmacy: 1-800-356-1561
New Jersey operates PAAD (Pharmaceutical Assistance to the Aged and Disabled) and the higher-income tier Senior Gold, both Medicare-recognized SPAPs that wrap around Medicare Part D for eligible enrollees. PAAD pays Part D premiums for many lower-income members and reduces copays. Senior Gold provides copay caps for higher-income seniors not eligible for PAAD. Both programs count as creditable Medicare coverage and PAAD/Senior Gold payments count toward TrOOP.
Eligibility: PAAD: age 65+ or disabled, NJ resident, income up to ~$52,142 (single) / $59,209 (married). Senior Gold: similar age/residency, higher income tier (PAAD + $10,000). Verify current thresholds on program site.
New Jersey permits 90-day fills of non-controlled chronic medications at retail and mail-order pharmacies. Out-of-state pharmacies must register as a Nonresident Pharmacy with the NJ Board of Pharmacy. NJ requires e-prescribing for all controlled substances under P.L. 2017, c. 28. Federal CSA refill limits apply.
New Jersey operates the NJPMP, administered by the Division of Consumer Affairs. Prescribers must check the NJPMP before issuing the first prescription of a Schedule II controlled substance and every three months during continued therapy. Pharmacists must report controlled-substance dispensing within one business day.
PMP portal: New Jersey Prescription Monitoring Program (NJPMP)
New Jersey hosts a substantial 340B network including RWJBarnabas Health, Hackensack Meridian, Rutgers University Hospital, FQHCs across Newark/Camden/Trenton, and Ryan White clinics. Uninsured New Jerseyans may access discounted outpatient drugs by establishing care at a covered entity. Use HRSA OPAIS filtered to New Jersey.
Find a 340B clinic in New Jersey: HRSA OPAIS database (NJ filter)
Our sister site OmniRx maintains a federal-side patient assistance program directory covering manufacturer PAPs, foundation copay assistance, GoodRx-style discount cards, and 340B locators applicable nationwide.
Once the law side is clear, the next question is which pharmacy actually has the cheapest fill. Use the RxGrab Pharmacy Finder to compare CostPlus Drugs, Costco, Walmart, Amazon Pharmacy, and other discount pharmacies on your specific medication, and read our generic vs brand explainer for the bioequivalence rules behind every substitution.
Yes by default they must under the NJ Generic Drug Substitution Act, unless your prescriber wrote "do not substitute" in their own handwriting.
PAAD (Pharmaceutical Assistance to the Aged and Disabled) is NJ's primary SPAP for residents 65+ or disabled, with income roughly under $52K single / $59K married (2026 thresholds, verify on program site). It pays Part D premiums for lower-income enrollees and reduces copays. Apply through the NJ Department of Human Services.
Senior Gold is the higher-income SPAP tier (PAAD income + $10,000). It caps copays at a fixed amount per prescription rather than paying Part D premiums.
Yes for the first prescription of a Schedule II controlled substance and every three months during continued therapy.